December 10, 2019
Lipidor (Nasdaq First North: LIPI) and Cannassure (TASE:CSURE) enter a feasibility study and licence option agreement for development and sales of topical medical cannabis products
Lipidor AB (“Lipidor”), a Swedish topical drug development company, and Cannassure Therapeutics Ltd (“Cannassure”), an Israel based developer and producer of innovative…